The mechanism of action of cagrilintide includes activating satiety centers in the brain, particularly hindbrain circuits, distinguishing it mechanistically from GLP-1 receptor agonists
Are comfortable with compounded medications
The most significant clinical data on retatrutide to date come from a Phase 2 randomised controlled trial published in the New England Journal of Medicine (2023), which evaluated the drug across multiple doses in adults with obesity
This process starts with gathering evidence, including medical records, expert testimonies, and research studies that might link Ozempic to potential health risks
Of note, prior to attempting intra-ventricular infusion of MT-II, we tried multiple different regimens of MT-II intra-peritoneal injections in the MIA mice
Large meals may feel heavier